Cargando…
Neonatal Fc receptor induces intravenous immunoglobulin growth suppression in Langerhans cell histiocytosis
The neonatal Fc receptor (FcRn) plays a role in trafficking IgG and albumin and is thought to mediate intravenous immunoglobulin (IVIG) therapy for certain diseases. IVIG can be used for the treatment of human Langerhans cell histiocytosis (LCH); however, the mechanism remains unclear. The expressio...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986110/ https://www.ncbi.nlm.nih.gov/pubmed/33497038 http://dx.doi.org/10.1111/pin.13068 |